# Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)

> **NCT05886712** · NA · ACTIVE_NOT_RECRUITING · sponsor: **RTI International** · enrollment: 31 (actual)

## Conditions studied

- Overdose
- Implementation as Usual

## Interventions

- **OTHER:** Naloxone
- **OTHER:** Usual intervention

## Key facts

- **NCT ID:** NCT05886712
- **Lead sponsor:** RTI International
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05886712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05886712, "Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05886712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*